Literature DB >> 3816530

Effect of methadone dose contingencies on urinalysis test results of polydrug-abusing methadone-maintenance patients.

M L Stitzer, W K Bickel, G E Bigelow, I A Liebson.   

Abstract

Drug abuse outcomes were examined during 2 contingency management procedures in which the size of the methadone dose was determined by recent urinalysis test results. Twenty polydrug-abusing methadone-maintenance patients were exposed to one of two specific altered dose consequences: a positive incentive procedure in which dose could only increase above baseline levels as a result of drug-free urines and a negative incentive procedure in which dose could only decrease below original baseline levels as a result of drug-positive urines. About 13% of urinalysis test results were drug-free during a 10-week pre-study baseline period while about 40-50% of urines were drug-free for both treatment groups during an 18-week intervention period. About half of the subjects in each study condition showed marked improvement during the intervention, while the other half failed to improve their urine test results. Treatment failures in the dose decrease as compared with the dose increase condition were more likely to drop out of the study. The study showed that size of the methadone dose can be effectively used as a consequence to influence illicit drug use during treatment. The study suggests that positive reinforcement as compared with aversive control procedures can produce an equivalent number of successful cases while avoiding dropout among patients who fail to respond to treatment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3816530     DOI: 10.1016/0376-8716(86)90097-9

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  22 in total

Review 1.  Choosing a behavioral therapy platform for pharmacotherapy of substance users.

Authors:  Kathleen M Carroll; Thomas R Kosten; Bruce J Rounsaville
Journal:  Drug Alcohol Depend       Date:  2004-08-16       Impact factor: 4.492

2.  The impact of enhanced incentives on vocational rehabilitation outcomes for dually diagnosed veterans.

Authors:  Charles E Drebing; E Alice Van Ormer; Christopher Krebs; Robert Rosenheck; Bruce Rounsaville; Lawrence Herz; Walter Penk
Journal:  J Appl Behav Anal       Date:  2005

3.  A perfect platform: combining contingency management with medications for drug abuse.

Authors:  Kathleen M Carroll; Bruce J Rounsaville
Journal:  Am J Drug Alcohol Abuse       Date:  2007       Impact factor: 3.829

Review 4.  Methadone maintenance treatment in opiate dependence: a review.

Authors:  M Farrell; J Ward; R Mattick; W Hall; G V Stimson; D des Jarlais; M Gossop; J Strang
Journal:  BMJ       Date:  1994-10-15

5.  A behavioral treatment for opioid-dependent patients with antisocial personality.

Authors:  Karin J Neufeld; Michael S Kidorf; Kenneth Kolodner; Van L King; Michael Clark; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2007-06-15

6.  Smoking reductions and increased self-efficacy in a randomized controlled trial of smoking abstinence-contingent incentives in residential substance abuse treatment patients.

Authors:  Sheila M Alessi; Nancy M Petry
Journal:  Nicotine Tob Res       Date:  2014-06-16       Impact factor: 4.244

7.  Contingent reinforcement of abstinence with individuals abusing cocaine and marijuana.

Authors:  A J Budney; S T Higgins; D D Delaney; L Kent; W K Bickel
Journal:  J Appl Behav Anal       Date:  1991

8.  Clinical evaluation and use of urine screening for drug abuse.

Authors:  A J Saxon; D A Calsyn; V M Haver; C J Delaney
Journal:  West J Med       Date:  1988-09

9.  Contingency management for cocaine treatment: cash vs. vouchers.

Authors:  David S Festinger; Karen L Dugosh; Kimberly C Kirby; Brittany L Seymour
Journal:  J Subst Abuse Treat       Date:  2014-03-06

Review 10.  Using behavioral reinforcement to improve methadone treatment participation.

Authors:  Robert K Brooner; Michael Kidorf
Journal:  Sci Pract Perspect       Date:  2002-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.